GAD1 and Parkinson disease: GAD is the rate-limiting enzyme for GABA synthesis, and PD affects the function of both GABA efferents to the subthalamic nucleus and their targets within the basal ganglia circuitry (Stoddard-Bennett and Reijo Pera, 2019; Muñoz et al., 2020).